The Road To Discovery: Emerging Therapies In Blood Cancers — The Leukemia & Lymphoma Society (LLS) will host a free patient education program on April 30 from 5:30 p.m. to 7:30 p.m. at The White Inn in Fredonia, NY. The program will discuss how new drugs are discovered, researched, and approved for treatment; recent and ongoing advances in the treatment of blood cancers; and participation in clinical trials as a possible treatment option. Pre-registration for this event is required on or before April 24. For more information, visit the LLS Web site.

Regatta Cup — The 2009 Leukemia Cup Regatta series, sponsored by the Leukemia & Lymphoma Society (LLS), will hold several fundraisers around the country throughout the month of May. Locations include San Diego; Panama City Beach, FL; Carlyle, MO; Southport, NC; and Lake Mission Viejo, CA. The annual Regatta Cup series has raised more than $27 million since its inception in 1988, with the 2008 events raising more than $3.6 million from 38 Regattas.

ARRY-520 Clinical Trials For Multiple Myeloma — Relapsed/refractory multiple myeloma patients are being recruited for a Phase 1/2 trial involving ARRY-520, a drug that prevents cancer cell reproduction. These Phase 1/2 clinical trials will test for safety and tolerability as well as disease response. For more information about the Phase 1/2 study, visit ClinicalTrials Web site. To learn more about ARRY-520, see the press release by ARRAY BioPharma.

For a more detailed listing of myeloma-related events, please check the Myeloma Beacon Events Calendar.